US$ 20.66
blindness from glp 1 Lipsitz, Ponterio & Comerford People Going Blind From GLP-1:
Description
Esposito, The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes

This finding indicated that JWU-A021 might be a TRPA1 cation channel activator

Some people need to stay at a dose longer if side effects are bothersome

and its all connected
Future treatments like oral GLP-1s and Tirzepatide are also anticipated but tempered by concerns over cost and accessibility
